Back
Innate Pharma SA Vs. Ubiquiti Industry Stock Comparison
Sell
20
IPHA
Innate Pharma SA
Last Price:
1.91
Seasonality Move:
11.17%
Buy
60
UI
Ubiquiti
Last Price:
349.92
Seasonality Move:
8.75%
Sell
20
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.85. The Score for IPHA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Ubiquiti (UI)
is a Buy
Is Ubiquiti a Buy, Sell or Hold?
- The current Ubiquiti [UI] share price is $340.35. The Score for UI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- UI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 45.09 | Sell |
| Chaikin Money Flow: | 448 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.05) | Sell |
| Bollinger Bands (100): | (1.98 - 2.28) | Sell |
UI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.64 | Buy |
| Relative Strength Index (14 RSI): | 84.77 | Buy |
| Chaikin Money Flow: | 160421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (233.07 - 280.95) | Buy |
| Bollinger Bands (100): | (159.27 - 240.99) | Buy |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.87 | Sell |
| 20-day SMA: | 1.9 | Sell |
| 50-day SMA: | 2.09 | Sell |
| 200-day SMA: | 2.35 | Sell |
| 8-day EMA: | 1.87 | Sell |
| 20-day EMA: | 1.91 | Sell |
| 50-day EMA: | 2.03 | Sell |
| 200-day EMA: | 2.3 | Sell |
UI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 278.65 | Buy |
| 20-day SMA: | 263.15 | Buy |
| 50-day SMA: | 232.9 | Buy |
| 200-day SMA: | 161.87 | Buy |
| 8-day EMA: | 286.98 | Buy |
| 20-day EMA: | 266.13 | Buy |
| 50-day EMA: | 238.27 | Buy |
| 200-day EMA: | 184.83 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Ubiquiti Earnings Growth & UI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.01 per share, and an increase next year of $2.99 per share.
Innate Pharma SA Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ubiquiti Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||